RGC (Regencell) Net Sales Margin

Graphic logo of Regencell (RGC)

Unique patents and a robust foundation enable Regencell Bioscience to maintain high profitability. The current net profit margin time series on the GURU.Markets chart illustrates this trend, where 0.00 determines the latest valuation metric. Success is based on safe neurotreatment methods for children, although business development depends directly on clinical test results and regulatory approvals.

Regencell Bioscience (RGC) Net Margin: for the period 07/04/2022 - 11/19/2026

Analytical breakdowns and data insights for company Regencell (RGC)

Analysis of all company metrics:Regencell Corp - RGC
Flagship merchandise of Regencell Bioscience Ltd

Sales margins reflect the share of net profit in total revenue, allowing investors to differentiate real operational efficiency from an artificial reduction in development costs. By analyzing the monthly margin dynamics of Regencell Bioscience (RGC), one can assess the impact of regulatory approvals on the profitability of a business that, due to the specifics of biopharmaceuticals, remains completely independent of economic cycles and seasonal fluctuations.

Analysis of competing companies

BIIB: Net Sales Margin|Net Margin Neurocrine Biosciences Inc (NBIX)|Net Margin Axsome Therapeutics Inc|ACAD: Net Profit Rate|Net Sales Margin XENE|Net Sales Margin vikingtherapeutics.com (VKTX)|Net Margin Supernus SUPN|Net Profit Rate CPRX|denalitherapeutics.com - Net Sales Margin|Company Sales Margin Harmony Pharma HRMY|BHVN: Net Sales Margin|Net Margin Amylyx Pharmaceuticals, Inc. (AMLX)|TRVI (Trevi Therapeutics Inc) - Net Sales Margin|Net Return on Sales PRAX (Praxis Medicines)|Net Margin Anavex Life Sciences (AVXL)|Net Margin CBLL (CeriBell EEG)|Net Sales Margin PRTA (Prothena Corp)|alector.com (ALEC) - Net Margin|ANNX: Return on Sales by Net Profit|Net Margin Omeros|NGNE: Net Sales Margin|Return on Sales by Net Profit AC Immune|Return on Sales by Net Profit VYGR|Net Return on Sales NMRA (neumoratx.com)|Return on Sales by Net Profit SCLX (Scilex Holding Company, Inc.)|Net Margin TVGN (Tevogen Bio)|Net Margin Alpha Cognition ACOG|CGTX - Return on Sales by Net Profit|IKT - Net Margin|SAVA: Net Margin|Assertio Therapeutics (ASRT) - Net Margin|Net Margin Coya Therapeutics Inc (COYA)|Net Margin Vistagen|Net Return on Sales OVID (ovidrx.com)|Net Margin Acumen Pharmaceuticals, Inc. (ABOS)|CRVO - Net Margin|Alterity Therapeutics Ltd. - Return on Sales by Net Profit|CLNN - Return on Sales by Net Profit|PEPG - Net Margin|Company Sales Margin jupiterneurosciences.com JUNS|Relmada Therapeutics (RLMD) - Net Margin|ANVS (Annovis Bio, Inc.) - Net Margin|Net Margin gracetx.com|Net Sales Margin Firefly Neuroscience, Inc.|Net Margin ANEW Medical (KLTO)|NRSN - Net Margin|Net Sales Margin RVPH (Reviva Pharmaceuticals Holdings Inc.)|Company Net Profitability MTVA (metaviatx.com)|NeurAxis Inc. - Net Sales Margin|Company Sales Margin heliusmedical.com HSDT|PASG: Net Sales Margin|Neuphoria - Net Profit Rate|Return on Sales by Net Profit NERV|ATHA: Net Profit Rate|Net Margin Addex Therapeutics Ltd (ADXN)|ALZN (Alzamend Neuro Inc.) - Net Profit Rate|Net Sales Margin CYCN (cyclerion.com)|Net Profitability Margin Protagenic|KTTA: Return on Sales by Net Profit|Net Profit Rate CRGT (cortigent.com)|ATXI: Net Sales Margin|BCLI (BrainStorm Cell Therapeutics) - Net Margin|CARA (Cara Therapeutics Inc.) - Net Sales Margin|Net Margin CHRO|Return on Sales by Net Profit ELYM (Eliem Therapeutics)|Net Margin ITCI (Intra-Cellular Therapies Inc.)|Net Sales Margin LBPH (Longboard Pharma)|Net Sales Margin Marinus Pharmaceuticals Inc MRNS|NKGen Biotech Corp - Net Sales Margin|Net Profit Rate NRBO (NeuroBo Pharma)|SAGE (Sage Therapeutics, Inc) - Return on Sales by Net Profit|Net Return on Sales SNPX|Return on Sales by Net Profit TRVN|Net Margin VIGL|Net Sales Margin WENA|Company Sales Margin Cerevel